Published Version
Open DOI LinkAbstract
Herald Avocats is a French law firm involved in intellectual property law, pharmaceutical law and European Union law that provides services to healthcare, biotech and pharmaceutical companies.
Full Text
Open DOI Link
Sign-in/Register to access full text options Topics from this Paper
European Union Law- Intellectual Property Law
- Pharmaceutical Law
- EU Legal
- Pharmaceutical Companies + Show 5 more
Create a personalized feed of these topics
Get StartedSimilar Papers
A Human Rights Approach to Intellectual Property and Access to Medicines 
Relevant
Not Relevant
SSRN Electronic Journal
Jan 1, 2013
RelevantNot Relevant The Interface Between Intellectual Property and Information Technology Law RelevantNot Relevant
- May 20, 2021
RelevantNot Relevant Intellectual Property Law and Brexit: A Retreat or a Reaffirmation of Jurisdiction? RelevantNot Relevant
- Jun 30, 2017
RelevantNot Relevant The Interface of Competition and Intellectual Property Law – Taking Stock and Identifying New Challenges RelevantNot Relevant
- SSRN Electronic Journal
- Nov 6, 2018
RelevantNot Relevant Critical thinking in intellectual property law RelevantNot Relevant
- International Journal of Law and Management
- Jun 8, 2020
RelevantNot Relevant Chinese Intellectual Property and Technology Transfer Law by Professor Zheng Chengsi with Michael D. Pendleton RelevantNot Relevant
- Arbitration International
- Dec 1, 1990
RelevantNot Relevant The Institutionalization of Pharmaceutical Administration After the Korean Liberation: Focusing on Regulating the Pharmaceutical Affairs Law(Yaksabeop) in 1953 RelevantNot Relevant
- Korean Journal of Medical History
- Dec 31, 2013
RelevantNot Relevant When two worlds collide: a comprehensive approach to the intellectual property and investment law interface RelevantNot Relevant
- Journal of Intellectual Property Law & Practice
- Dec 25, 2020
RelevantNot RelevantREAD MORE FROMJournal of Generic Medicines: The Business Journal for the Generic Medicines Sector
Regulatory perspective of cancer drug development: An overview RelevantNot Relevant
- Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
- Sep 11, 2023
RelevantNot Relevant Lebanese pharmacists’ knowledge of generic drugs and factors affecting their use and selection following the pandemic and the economic crisis: A pilot cross-sectional study RelevantNot Relevant
- Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
- Sep 6, 2023
RelevantNot Relevant Regulatory framework and disparities of complex generics in United States, European Union & Latin America RelevantNot Relevant
- Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
- Sep 1, 2023
RelevantNot Relevant EU legal and regulatory update JULY 2023 RelevantNot Relevant
- Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
- Sep 1, 2023
RelevantNot Relevant Comparison of pharmaceutical characteristics and membrane permeability of truvada combination tablets and its generic drugs RelevantNot Relevant
- Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
- Aug 22, 2023
RelevantNot Relevant Generic drug labeling: Recent developments since Pliva, Inc. v. Mensing RelevantNot Relevant
- Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
- Jul 28, 2023
RelevantNot Relevant An overview of over-the-counter monograph system in US RelevantNot Relevant
- Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
- Jun 26, 2023
RelevantNot Relevant EU legal and regulatory update APRIL 2023 RelevantNot Relevant
- Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
- Jun 1, 2023
RelevantNot Relevant The journal of generic medicines – Editorial June 2023 RelevantNot Relevant
- Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
- May 9, 2023
RelevantNot Relevant Precision medicine patent prosecution at the USPTO: What can be expected? RelevantNot Relevant
- Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
- Apr 28, 2023
RelevantNot Relevant